Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108741132> ?p ?o ?g. }
- W2108741132 endingPage "585" @default.
- W2108741132 startingPage "579" @default.
- W2108741132 abstract "ABSTRACT Invasive pulmonary aspergillosis (IPA) is a devastating disease of immunocompromised patients. Pharmacodynamic (PD) examination of antifungal drug therapy in IPA is one strategy that may improve outcomes. The current study explored the PD target of posaconazole in an immunocompromised murine model of IPA against 10 A. fumigatus isolates, including 4 Cyp51 wild-type isolates and 6 isolates carrying Cyp51 mutations conferring azole resistance. The posaconazole MIC range was 0.25 to 8 mg/liter. Following infection, mice were given 0.156 to 160 mg/kg of body weight of oral posaconazole daily for 7 days. Efficacy was assessed by quantitative PCR (qPCR) of lung homogenate and survival. At the start of therapy, mice had 5.59 ± 0.19 log 10 Aspergillus conidial equivalents (CE)/ml of lung homogenate, which increased to 7.11 ± 0.29 log 10 CE/ml of lung homogenate in untreated animals. The infection was uniformly lethal prior to the study endpoint in control mice. A Hill-type dose response function was used to model the relationship between posaconazole free drug area under the concentration-time curve (AUC)/MIC and qPCR lung burden. The static dose range was 1.09 to 51.9 mg/kg/24 h. The free drug AUC/MIC PD target was 1.09 ± 0.63 for the group of strains. The 1-log kill free drug AUC/MIC was 2.07 ± 1.02. The PD target was not significantly different for the wild-type and mutant organism groups. Mortality mirrored qPCR results, with the greatest improvement in survival noted at the same dosing regimens that produced static or cidal activity. Consideration of human pharmacokinetic data and the current static dose PD target would predict a clinical MIC threshold of 0.25 to 0.5 mg/liter." @default.
- W2108741132 created "2016-06-24" @default.
- W2108741132 creator A5028256879 @default.
- W2108741132 creator A5046771520 @default.
- W2108741132 creator A5080419280 @default.
- W2108741132 creator A5086438124 @default.
- W2108741132 date "2013-01-01" @default.
- W2108741132 modified "2023-09-23" @default.
- W2108741132 title "Posaconazole Pharmacodynamic Target Determination against Wild-Type and <i>Cyp51</i> Mutant Isolates of Aspergillus fumigatus in an <i>In Vivo</i> Model of Invasive Pulmonary Aspergillosis" @default.
- W2108741132 cites W111826357 @default.
- W2108741132 cites W1583402793 @default.
- W2108741132 cites W1976824086 @default.
- W2108741132 cites W1988385266 @default.
- W2108741132 cites W1989345554 @default.
- W2108741132 cites W1990371288 @default.
- W2108741132 cites W1997351409 @default.
- W2108741132 cites W2006991283 @default.
- W2108741132 cites W2012538966 @default.
- W2108741132 cites W2014557179 @default.
- W2108741132 cites W2023900788 @default.
- W2108741132 cites W2026574962 @default.
- W2108741132 cites W2032321007 @default.
- W2108741132 cites W2049465796 @default.
- W2108741132 cites W2051723321 @default.
- W2108741132 cites W2054459659 @default.
- W2108741132 cites W2079691262 @default.
- W2108741132 cites W2091637502 @default.
- W2108741132 cites W2095837810 @default.
- W2108741132 cites W2097412017 @default.
- W2108741132 cites W2097822381 @default.
- W2108741132 cites W2098072609 @default.
- W2108741132 cites W2098714617 @default.
- W2108741132 cites W2106243271 @default.
- W2108741132 cites W2106962923 @default.
- W2108741132 cites W2107531307 @default.
- W2108741132 cites W2107846217 @default.
- W2108741132 cites W2109396161 @default.
- W2108741132 cites W2109814431 @default.
- W2108741132 cites W2111311989 @default.
- W2108741132 cites W2113717321 @default.
- W2108741132 cites W2115422838 @default.
- W2108741132 cites W2115769369 @default.
- W2108741132 cites W2119596469 @default.
- W2108741132 cites W2123134253 @default.
- W2108741132 cites W2126064588 @default.
- W2108741132 cites W2127982840 @default.
- W2108741132 cites W2132002261 @default.
- W2108741132 cites W2133167433 @default.
- W2108741132 cites W2134458167 @default.
- W2108741132 cites W2135315031 @default.
- W2108741132 cites W2136501331 @default.
- W2108741132 cites W2137209084 @default.
- W2108741132 cites W2142005104 @default.
- W2108741132 cites W2144126572 @default.
- W2108741132 cites W2144392264 @default.
- W2108741132 cites W2144677985 @default.
- W2108741132 cites W2148354791 @default.
- W2108741132 cites W2149925685 @default.
- W2108741132 cites W2150760368 @default.
- W2108741132 cites W2151939809 @default.
- W2108741132 cites W2157646868 @default.
- W2108741132 cites W2162857158 @default.
- W2108741132 cites W2164337152 @default.
- W2108741132 cites W2166682252 @default.
- W2108741132 cites W2169748580 @default.
- W2108741132 cites W2170688673 @default.
- W2108741132 cites W2171105924 @default.
- W2108741132 cites W2171466020 @default.
- W2108741132 doi "https://doi.org/10.1128/aac.01279-12" @default.
- W2108741132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3535976" @default.
- W2108741132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23147740" @default.
- W2108741132 hasPublicationYear "2013" @default.
- W2108741132 type Work @default.
- W2108741132 sameAs 2108741132 @default.
- W2108741132 citedByCount "65" @default.
- W2108741132 countsByYear W21087411322013 @default.
- W2108741132 countsByYear W21087411322014 @default.
- W2108741132 countsByYear W21087411322015 @default.
- W2108741132 countsByYear W21087411322016 @default.
- W2108741132 countsByYear W21087411322017 @default.
- W2108741132 countsByYear W21087411322018 @default.
- W2108741132 countsByYear W21087411322019 @default.
- W2108741132 countsByYear W21087411322020 @default.
- W2108741132 countsByYear W21087411322021 @default.
- W2108741132 countsByYear W21087411322022 @default.
- W2108741132 countsByYear W21087411322023 @default.
- W2108741132 crossrefType "journal-article" @default.
- W2108741132 hasAuthorship W2108741132A5028256879 @default.
- W2108741132 hasAuthorship W2108741132A5046771520 @default.
- W2108741132 hasAuthorship W2108741132A5080419280 @default.
- W2108741132 hasAuthorship W2108741132A5086438124 @default.
- W2108741132 hasBestOaLocation W21087411321 @default.
- W2108741132 hasConcept C111113717 @default.
- W2108741132 hasConcept C112705442 @default.
- W2108741132 hasConcept C126322002 @default.
- W2108741132 hasConcept C150903083 @default.
- W2108741132 hasConcept C203014093 @default.
- W2108741132 hasConcept C207001950 @default.